{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:31:32Z","timestamp":1792085492677,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pregnant and puerperal women are at increased risk of venous thromboembolism (VTE) owing to hemostatic changes in preparation for childbirth. The objective of this study was to investigate if COVID-19 infection was associated with VTE in pregnancy or 12 weeks postpartum when considering (prophylactic or therapeutic) anticoagulant use. This population-based register study included all women in Sweden and Norway giving birth after 22 gestational weeks, with conception dates from March 2020 to 2022. A PCR-verified COVID-19 test was used as the exposure, and a VTE diagnosis during pregnancy or 12 weeks postpartum was the outcome. Non-infected women consisted of those testing negative and untested individuals. Cox regression analyses, with COVID-19 infection as a time-varying exposure, and adjusted for maternal characteristics and anticoagulant use, provided overall hazard ratios. To evaluate whether there was a particular increased risk of VTE shortly after testing positive for COVID-19, we estimated time-specific risk of VTE in the first 2, 4, 8, 12, and 16 weeks following COVID-19 infection. Data from each country were first analyzed separately and then meta-analyzed. Among 323,868 participants, 46,048 (14.2%) had COVID-19 during pregnancy, and 80 (0.2%) were diagnosed with VTE. Pregnant women with COVID-19 had a higher VTE incidence rate compared to non-infected (4.9 vs. 2.9 per 1000 person-years; adjusted overall hazard ratio [aHR] 1.26, 95% Confidence Interval [CI] 0.80-2.00). The highest risk was within two weeks of infection (aHR 4.63, 95% CI 2.71\u20137.90) but remained elevated up to 12 weeks post-infection (aHR 1.86, 95% CI 1.17\u20132.94). In the postpartum period, 8,515 (2.6%) had COVID-19, and 6 (0.07%) were diagnosed with VTE (aHR 5.17, 95% CI 2.50-10.69). Although VTE post-COVID-19 infection was rare, the infection was associated with increased VTE risk during pregnancy and postpartum, even after adjusting for anticoagulant use. These findings should contribute to the individual risk assessment when evaluating the need for prophylactic anticoagulants in pregnancy and postpartum.<\/jats:p>","DOI":"10.1007\/s10654-025-01268-z","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:23:00Z","timestamp":1752207780000},"page":"779-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 infection increases the risk of venous thromboembolism during pregnancy and the postpartum period"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-9233","authenticated-orcid":false,"given":"Anne K.","family":"\u00d6rtqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"S\u00f6derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Kjaer","family":"Urhoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri E.","family":"H\u00e5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Stephansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"12","key":"1268_CR1","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1055\/s-0040-1718532","volume":"120","author":"S Schulman","year":"2020","unstructured":"Schulman S, Hu Y, Konstantinides S. Venous thromboembolism in COVID-19. Thromb Haemost. 2020;120(12):1642\u201353.","journal-title":"Thromb Haemost"},{"issue":"7","key":"1268_CR2","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jth.14869","volume":"18","author":"JF Llitjos","year":"2020","unstructured":"Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743\u20136.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"1268_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/aogs.13962","volume":"99","author":"R D\u2019Souza","year":"2020","unstructured":"D\u2019Souza R, Malham\u00e9 I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020;99(9):1110\u201320.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"1268_CR4","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438\u201340.","journal-title":"Lancet Haematol"},{"key":"1268_CR5","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstetrics and gynecology. 2018;132(1):e1-e17.","DOI":"10.1097\/AOG.0000000000002706"},{"issue":"19","key":"1268_CR6","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMra0707993","volume":"359","author":"PE Marik","year":"2008","unstructured":"Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008;359(19):2025\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"1268_CR7","doi-asserted-by":"publisher","first-page":"e233231","DOI":"10.1016\/j.ajog.2007.08.041","volume":"198","author":"AF Jacobsen","year":"2008","unstructured":"Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium\u2013a register-based case-control study. Am J Obstet Gynecol. 2008;198(2):e233231\u2013237.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1268_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1034\/j.1600-0412.1998.770207.x","volume":"77","author":"BS Andersen","year":"1998","unstructured":"Andersen BS, Steffensen FH, S\u00f8rensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium\u2013an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand. 1998;77(2):170\u20133.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1268_CR9","first-page":"CD001689","volume":"3","author":"P Middleton","year":"2021","unstructured":"Middleton P, Shepherd E, Gomersall JC. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2021;3:CD001689.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1268_CR10","doi-asserted-by":"publisher","first-page":"100654","DOI":"10.1016\/j.ajogmf.2022.100654","volume":"4","author":"R Di Girolamo","year":"2022","unstructured":"Di Girolamo R, Khalil A, Rizzo G, et al. Systematic review and critical evaluation of quality of clinical practice guidelines on the management of SARS-CoV-2 infection in pregnancy. Am J Obstet Gynecol MFM. 2022;4(5):100654.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1268_CR11","unstructured":"Swedish Society of Obstetrics and Gynecology. Guidelines regarding thromboprophylaxis in pregnancy due to COVID-19 [homepage on the Internet, in Swedish] 2020; [updated 4 Feb 2022; cited 4 Oct 2024] Available from: https:\/\/www.sfog.se\/media\/337859\/hemostasutredning-och-behandling-av-venoes-tromboembolism-vte-samt-trombosprofylax-vid-covid-19-hos-obstetriska-patienter-final.pdf"},{"key":"1268_CR12","unstructured":"Norsk gynekologisk forening. Coronavirus during pregnancy and postpartum [homepage on the Internet, in Norwegian] 2020; [cited 4 Oct 2024] Available from: Covid-19 og ven\u00f8s tromboembolisme\u2013 profylakse og behandling| Tidsskrift for Den norske legeforening (tidsskriftet.no)."},{"issue":"1","key":"1268_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/1471-0528.16969","volume":"129","author":"MC Magnus","year":"2022","unstructured":"Magnus MC, Oakley L, Gjessing HK, et al. Pregnancy and risk of COVID-19: a Norwegian registry-linkage study. BJOG. 2022;129(1):101\u20139.","journal-title":"BJOG"},{"issue":"5","key":"1268_CR14","doi-asserted-by":"publisher","first-page":"e2314678","DOI":"10.1001\/jamanetworkopen.2023.14678","volume":"6","author":"JJ Byrne","year":"2023","unstructured":"Byrne JJ, Shamshirsaz AA, Cahill AG, et al. Outcomes following extracorporeal membrane oxygenation for severe COVID-19 in pregnancy or post partum. JAMA Netw Open. 2023;6(5):e2314678.","journal-title":"JAMA Netw Open"},{"key":"1268_CR15","doi-asserted-by":"crossref","unstructured":"Magnus MC, \u00d6rtqvist AK, Urhoj SK et al. Infection with SARS-CoV-2 during pregnancy and risk of stillbirth: a Scandinavian registry study. BMJ Public Health. 2023;1(1).","DOI":"10.1136\/bmjph-2023-000314"},{"issue":"3","key":"1268_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/aogs.14512","volume":"102","author":"AJM Aabakke","year":"2023","unstructured":"Aabakke AJM, Petersen TG, Wojdemann K, et al. Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis. Acta Obstet Gynecol Scand. 2023;102(3):282\u201393.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"20","key":"1268_CR17","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1001\/jama.2021.5775","volume":"325","author":"M Norman","year":"2021","unstructured":"Norman M, Naver L, Soderling J, et al. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA. 2021;325(20):2076\u201386.","journal-title":"JAMA"},{"issue":"5","key":"1268_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamainternmed.2020.9241","volume":"181","author":"KS Jering","year":"2021","unstructured":"Jering KS, Claggett BL, Cunningham JW, et al. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. 2021;181(5):714\u20137.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1268_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/AOG.0000000000005387","volume":"143","author":"AM Bruno","year":"2024","unstructured":"Bruno AM, Horns JJ, Metz TD. Coronavirus disease 2019 (COVID-19) and venous thromboembolism during pregnancy and postpartum. Obstet Gynecol. 2024;143(1):139\u201342.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1268_CR20","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1038\/s41467-023-40965-9","volume":"14","author":"L Lindsay","year":"2023","unstructured":"Lindsay L, Calvert C, Shi T, et al. Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study. Nat Commun. 2023;14(1):5275.","journal-title":"Nat Commun"},{"issue":"4","key":"1268_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/aogs.13266","volume":"97","author":"O Stephansson","year":"2018","unstructured":"Stephansson O, Petersson K, Bjork C, Conner P, Wikstrom AK. The Swedish pregnancy Register - for quality of care improvement and research. Acta Obstet Gynecol Scand. 2018;97(4):466\u201376.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1268_CR22","unstructured":"Norwegian Institute of Public Health. Medical Birth Registry of Norway [homepage on the Internet] 2024; [cited 4 Oct 2024] Available from: https:\/\/www.fhi.no\/en\/ch\/medical-birth-registry-of-norway\/"},{"key":"1268_CR23","unstructured":"The Public Health Agency of Sweden. Statistics on SARS-CoV-2 variants of special interest [homepage on the Internet] 2022; [cited 4 Oct 2024] Available from: https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/covid-19-veckorapporter\/"},{"issue":"1","key":"1268_CR24","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.1038\/s41598-022-12395-y","volume":"12","author":"AK Ortqvist","year":"2022","unstructured":"Ortqvist AK, Magnus MC, Soderling J, et al. The association between maternal characteristics and SARS-CoV-2 in pregnancy: a population-based registry study in Sweden and Norway. Sci Rep. 2022;12(1):8355.","journal-title":"Sci Rep"},{"issue":"12","key":"1268_CR25","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/apa.15582","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF. The first eight months of sweden\u2019s COVID-19 strategy and the key actions and actors that were involved. Acta Paediatr. 2020;109(12):2459\u201371.","journal-title":"Acta Paediatr"},{"issue":"11","key":"1268_CR26","doi-asserted-by":"publisher","first-page":"e008864","DOI":"10.1136\/bmjopen-2015-008864","volume":"5","author":"A Abdul Sultan","year":"2015","unstructured":"Abdul Sultan A, West J, Stephansson O, et al. Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study. BMJ Open. 2015;5(11):e008864.","journal-title":"BMJ Open"},{"key":"1268_CR27","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"\u00d8 Lidegaard","year":"2011","unstructured":"Lidegaard \u00d8, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139. BMJ. 2011;343:d6423.","journal-title":"BMJ"},{"key":"1268_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-2125.2000.00199.x","volume":"49","author":"R Lawrenson","year":"2000","unstructured":"Lawrenson R, Todd JC, Leydon GM, et al. Validation of the diagnosis of venous thromboembolism in general practice database studies. BrJ Clin Pharmacol. 2000;49:591\u20136.","journal-title":"BrJ Clin Pharmacol"},{"issue":"5","key":"1268_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bcpt.12613","volume":"119","author":"SM Wallerstedt","year":"2016","unstructured":"Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish prescribed drug Register - A systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1268_CR30","unstructured":"The Norwegian Prescription Database (NorPD) [homepage on the Internet]. 2024; [cited 4 Oct 2024] Available from: https:\/\/www.norpd.no\/"},{"key":"1268_CR31","unstructured":"Statistics Sweden. Population registers [homepage on the Internet] 2024; [cited 4 Oct 2024] Available from: https:\/\/www.scb.se\/vara-tjanster\/bestall-data-och-statistik\/"},{"key":"1268_CR32","unstructured":"Statistics Norway. [homepage on the Internet] 2024; [cited 4 Oct 2024] https:\/\/www.ssb.no\/en\/"},{"key":"1268_CR33","unstructured":"The Public Health Agency of Sweden. National vaccination program and vaccination register. [homepage on the Internet, in Swedish] 2024; [cited 4 Oct 2024] Available from: https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/nationella-vaccinationsregistret\/"},{"issue":"12","key":"1268_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.122.060785","volume":"146","author":"R Knight","year":"2022","unstructured":"Knight R, Walker V, Ip S, et al. Association of COVID-19 with major arterial and venous thrombotic diseases: A Population-Wide cohort study of 48 million adults in England and Wales. Circulation. 2022;146(12):892\u2013906.","journal-title":"Circulation"},{"key":"1268_CR35","doi-asserted-by":"publisher","first-page":"n1931","DOI":"10.1136\/bmj.n1931","volume":"374","author":"J Hippisley-Cox","year":"2021","unstructured":"Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931.","journal-title":"BMJ"},{"issue":"12","key":"1268_CR36","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","volume":"128","author":"ME Colling","year":"2021","unstructured":"Colling ME, Tourdot BE, Kanthi Y. Inflammation, infection and venous thromboembolism. Circ Res. 2021;128(12):2017\u201336.","journal-title":"Circ Res"},{"issue":"6","key":"1268_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/aogs.14552","volume":"102","author":"AK Ortqvist","year":"2023","unstructured":"Ortqvist AK, Magnus MC, Aabakke AJM, et al. Severe COVID-19 during pregnancy in sweden, norway, and Denmark. Acta Obstet Gynecol Scand. 2023;102(6):681\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"1268_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/AOG.0000000000004849","volume":"140","author":"AR Seasely","year":"2022","unstructured":"Seasely AR, Blanchard CT, Arora N, et al. Maternal and perinatal outcomes associated with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Obstet Gynecol. 2022;140(2):262\u20135.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1268_CR39","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.rpth.2024.102339","volume":"8","author":"M Othman","year":"2024","unstructured":"Othman M, Nemeti G, Solow M, et al. Hematologic characteristics and coagulopathy in pregnancy with COVID-19 succeeding the first wave: a multicenter retrospective cross-sectional study. Res Pract Thromb Haemostasis. 2024;8(1):102339.","journal-title":"Res Pract Thromb Haemostasis"},{"issue":"4","key":"1268_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","volume":"137","author":"TD Metz","year":"2021","unstructured":"Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571\u201380.","journal-title":"Obstet Gynecol"},{"key":"1268_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish National inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01268-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-025-01268-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01268-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:56:06Z","timestamp":1757220966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-025-01268-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1268"],"URL":"https:\/\/doi.org\/10.1007\/s10654-025-01268-z","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"O.S. is the Co-founder of the pregnancy application One Million Babies. The remaining authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Swedish Ethical Review Authority (No. 2020\u2009\u2212\u200901499, 2020\u201302468, 2021\u2009\u2212\u200900274) and the Regional Committee for Medical and Health Research Ethics of South\/East Norway (No.141135) approved this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The Swedish Ethical Review Authority (No. 2020\u2009\u2212\u200901499, 2020\u201302468, 2021\u2009\u2212\u200900274) and the Regional Committee for Medical and Health Research Ethics of South\/East Norway (No. 141135) provided a waiver of consent for registered individuals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}